Recent Advancement in Exosome-Inspired Lipid Nanovesicles for Cell-Specific Drug Delivery

被引:1
|
作者
Sunkara, Siva Prasad [1 ]
Kar, Nihar Ranjan [2 ]
Kareemulla, Shaik [3 ]
Sarma, Koushik Narayan [4 ]
Thool, Komal Umare [5 ]
Katual, Manoj Kumar [6 ]
Kondrapu, Pydiraju [7 ]
机构
[1] Chebrolu Hanumaiah Inst Pharmaceut Sci, Dept Pharm, Guntur, Andhra Prades, India
[2] Centur Univ Technol & Management, Dept Pharm, Balasore, Odisha, India
[3] Maharishi Markandeshwar Deemed Univ, MM Coll Pharm, Dept Pharm Practice, Ambala, Haryana, India
[4] Assam Town Univ, Dept Pharm, Gauhati, Assam, India
[5] Shree Ramdevbaba Coll Engn & Management Nagpur, Dept Elect & Commun Engn, Nagpur, Maharashtra, India
[6] Guru Kashi Univ, Univ Coll Pharm, Dept Pharmaceut, Sardulgarh Rd, Bhatinda, Punjab, India
[7] Aditya Pharm Coll, Dept Pharm, ADB Rd, Kakinada 533437, Andhra Prades, India
关键词
Exosome; Exo-LNVs; Surface modification; Drug delivery system; Extracellular vesicles; Therapeutic cargo; EXTRACELLULAR VESICLES; NANO-CARRIERS; TRANSPORT; RELEASE;
D O I
10.5530/ijpi.14.4.119
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exosomes are small nanovesicles that are produced through the fusion of multiple veins and plasma membranes, then escaping into adjacent body fluids. Considerable attention has been paid to them due to their potential as delivery vehicles for drugs. Exosomes play a key role in many physiological processes that occur both in healthy and ill states. The production of exosomes depends on the state of the disease, but the disease itself often serves the opposite function by promoting more cell damage and stress. Traditional drug delivery methods often face limitations in terms of specificity, targeted delivery and drug release kinetics. Exosomes have emerged as promising candidates for drug delivery due to their natural ability to selectively deliver cargoes to recipient cells. Exosomes are taken up through various mechanisms, including endocytosis and fusion with target cells. They can encapsulate poorly soluble drugs, enhancing their bioavailability and improving their therapeutic efficacy. Exosomes inspired Lipid Nanovesicles (Exo-LNVs) have shown promising results as drug delivery vehicles. Exosomes have considerable potential as sophisticated vehicle for the delivery of targeted drugs and genes due to their unique characteristics, including inherent stability, minimal immunity and exceptional ability to penetrate tissues and cells. Therapeutic interventions have the capacity to increase effectiveness, reduce side effects and increase patient compliance. Exosomes have the ability to transport various therapeutic by encapsulating different substrates such as nucleic acids, proteins and small molecules. Recent advancements in exosome-inspired lipid nanovesicles have opened up new possibilities for cell-specific drug delivery. These nanovesicles mimic the composition and structure of exosomes, which are naturally occurring extracellular vesicles released by cells. By incorporating therapeutic agents into the lipid nanovesicles, they can effectively target and deliver drugs to specific cells of interest. This review article aims to summarize the current literature on Exo-LNVs and discuss their potential as drug delivery vehicles. A systematic search was conducted to identify relevant studies and relevant data were extracted and analyzed. The review covers various aspects of Exo-LNVs, including their composition, preparation methods and applications in various disease conditions.
引用
收藏
页码:1085 / 1095
页数:11
相关论文
共 50 条
  • [31] Surface modification of lipid-based nanocarriers for cancer cell-specific drug targeting
    Kim C.H.
    Lee S.G.
    Kang M.J.
    Lee S.
    Choi Y.W.
    Journal of Pharmaceutical Investigation, 2017, 47 (3) : 203 - 227
  • [32] GENE DELIVERY Cell-specific therapy on target
    Clarke, Daniel T. W.
    McMillan, Nigel A. J.
    NATURE NANOTECHNOLOGY, 2014, 9 (08) : 568 - 569
  • [33] Cell-specific delivery of genes with glycosylated carriers
    Hashida, M
    Nishikawa, M
    Yamashita, F
    Takakura, Y
    ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (03) : 187 - 196
  • [34] CELL-SPECIFIC SIRNA DELIVERY BY PEPTIDES AND ANTIBODIES
    Lee, Sang-Kyung
    Siefert, Alyssa
    Beloor, Jagadish
    Fahmy, Tarek M.
    Kumar, Priti
    METHODS IN ENZYMOLOGY, VOL 502: PROTEIN ENGINEERING FOR THERAPEUTICS, PT A, 2012, 502 : 91 - 122
  • [35] Potential of nano carriers as cancer cell-specific drug delivery systems in photodynamic therapy
    Chang-Koo Shim
    Ji-Eun Chang
    Asian Journal of Pharmaceutical Sciences, 2016, 11 (01) : 8 - 9
  • [36] Recent Advances in Exosome-Based Drug Delivery for Cancer Therapy
    Kim, Hyosuk
    Jang, Hochung
    Cho, Haeun
    Choi, Jiwon
    Hwang, Kwang Yeon
    Choi, Yeonho
    Kim, Sun Hwa
    Yang, Yoosoo
    CANCERS, 2021, 13 (17)
  • [37] Plasmonic nanobubbles for target cell-specific gene and drug delivery and multifunctional processing of heterogeneous cell systems
    Lukianova-Hleb, Ekaterina Y.
    Huye, Leslie E.
    Brenner, Malcolm K.
    Lapotko, Dmitri O.
    FRONTIERS IN ULTRAFAST OPTICS: BIOMEDICAL, SCIENTIFIC, AND INDUSTRIAL APPLICATIONS XIV, 2014, 8972
  • [38] Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery
    M. Sala
    F. Locher
    M. Bonvallet
    G. Agusti
    A. Elaissari
    H. Fessi
    Pharmaceutical Research, 2017, 34 : 1908 - 1924
  • [39] Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery
    Sala, M.
    Locher, F.
    Bonvallet, M.
    Agusti, G.
    Elaissari, A.
    Fessi, H.
    PHARMACEUTICAL RESEARCH, 2017, 34 (09) : 1908 - 1924
  • [40] Tumor Endothelial Cell-Specific Drug Delivery System Using Apelin-Conjugated Liposomes
    Kawahara, Hiroki
    Naito, Hisamichi
    Takara, Kazuhiro
    Wakabayashi, Taku
    Kidoya, Hiroyasu
    Takakura, Nobuyuki
    PLOS ONE, 2013, 8 (06):